$1.30
0.032.36%
At close: -
$1.32
0.021.54%
After Hours: 5:52 PM EDT
Comments
Loading...
Editas Medicine Earnings Estimates, EPS & Revenue | NASDAQ:EDIT | Benzinga
Editas Medicine reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 5
EPS
$-0.400
Quarterly Revenue
$30.60M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$32.31M
Analyze the earnings history of Editas Medicine using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EDIT | Editas Medicine | -$0.76 | — | — | — | $1.14M | — | — | — | 05/07/2025 | Get Alert |
| EDIT | Editas Medicine | -$0.23 | -$0.38 | -$0.40 | -5.26% | $60.05M | $32.23M | $30.60M | -5.04% | 03/05/2025 | Get Alert |
| EDIT | Editas Medicine | -$0.55 | -$0.78 | -$0.75 | 3.85% | $5.34M | $2.69M | $61.00K | -97.73% | 11/04/2024 | Get Alert |
| EDIT | Editas Medicine | -$0.56 | -$0.70 | -$0.82 | -17.14% | $2.89M | $5.08M | $513.00K | -89.90% | 08/07/2024 | Get Alert |
| EDIT | Editas Medicine | -$0.71 | -$0.67 | -$0.76 | -13.43% | $9.85M | $7.90M | $1.14M | -85.63% | 05/08/2024 | Get Alert |
| EDIT | Editas Medicine | -$0.88 | -$0.54 | -$0.23 | 57.41% | $6.54M | $7.94M | $60.05M | 656.30% | 02/28/2024 | Get Alert |
| EDIT | Editas Medicine | -$0.81 | -$0.57 | -$0.55 | 3.51% | $42.00K | $3.42M | $5.34M | 56.02% | 11/03/2023 | Get Alert |
| EDIT | Editas Medicine | -$0.78 | -$0.76 | -$0.56 | 26.32% | $6.36M | $6.28M | $2.89M | -54.03% | 08/02/2023 | Get Alert |
| EDIT | Editas Medicine | -$0.74 | -$0.78 | -$0.71 | 8.97% | $6.77M | $3.01M | $9.85M | 227.28% | 05/05/2023 | Get Alert |
| EDIT | Editas Medicine | -$0.61 | -$0.80 | -$0.88 | -10.00% | $12.47M | $3.26M | $6.54M | 100.49% | 02/22/2023 | Get Alert |
| EDIT | Editas Medicine | -$0.57 | -$0.86 | -$0.81 | 5.81% | $6.20M | $4.73M | $42.00K | -99.11% | 11/02/2022 | Get Alert |
| EDIT | Editas Medicine | -$0.81 | -$0.82 | -$0.78 | 4.88% | $379.00K | $4.29M | $6.36M | 48.30% | 08/03/2022 | Get Alert |
| EDIT | Editas Medicine | -$0.86 | -$0.79 | -$0.74 | 6.33% | $6.50M | $3.85M | $6.77M | 75.87% | 05/04/2022 | Get Alert |
| EDIT | Editas Medicine | -$1.00 | -$0.72 | -$0.61 | 15.28% | $11.42M | $4.29M | $12.47M | 190.65% | 02/24/2022 | Get Alert |
| EDIT | Editas Medicine | $0.12 | -$0.82 | -$0.57 | 30.49% | $62.84M | $4.78M | $6.20M | 29.64% | 11/08/2021 | Get Alert |
| EDIT | Editas Medicine | -$0.43 | -$0.83 | -$0.81 | 2.41% | $10.75M | $6.17M | $379.00K | -93.86% | 08/04/2021 | Get Alert |
| EDIT | Editas Medicine | -$0.69 | -$0.75 | -$0.86 | -14.67% | $5.72M | $5.14M | $6.50M | 26.44% | 05/05/2021 | Get Alert |
| EDIT | Editas Medicine | -$0.74 | -$0.74 | -$1.00 | -35.14% | $12.28M | $5.64M | $11.42M | 102.46% | 02/25/2021 | Get Alert |
| EDIT | Editas Medicine | -$0.66 | -$0.61 | $0.12 | 119.67% | $3.85M | $6.36M | $62.84M | 888.07% | 11/05/2020 | Get Alert |
| EDIT | Editas Medicine | -$0.69 | -$0.79 | -$0.43 | 45.57% | $2.33M | $6.34M | $10.75M | 69.54% | 08/06/2020 | Get Alert |
| EDIT | Editas Medicine | -$0.60 | -$0.77 | -$0.69 | 10.39% | $2.07M | $7.02M | $5.72M | -18.48% | 05/07/2020 | Get Alert |
Editas Medicine (EDIT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-05 | $-0.40 | $-0.38 | -5.26 % |
| Q3 | 2024-11-04 | $-0.75 | $-0.78 | 3.85 % |
| Q2 | 2024-08-07 | $-0.82 | $-0.70 | -17.1 % |
| Q1 | 2024-05-08 | $-0.76 | $-0.67 | -13.4 % |
Editas Medicine (EDIT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-05 | $30.60M | $32.23M | -5.04 % |
| Q3 | 2024-11-04 | $61.00K | $2.69M | -97.7 % |
| Q2 | 2024-08-07 | $513.00K | $5.08M | -89.9 % |
| Q1 | 2024-05-08 | $1.14M | $7.90M | -85.6 % |
FAQ
When is Editas Medicine (NASDAQ:EDIT) reporting earnings?
Editas Medicine (EDIT) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on March 5, 2025 for Q4.
What were the latest earnings per share (EPS) for Editas Medicine (NASDAQ:EDIT)?
The Actual EPS was $-0.40, which missed the estimate of $-0.38.
What were Editas Medicine’s (NASDAQ:EDIT) revenues?
The Actual Revenue was $30.6M, which missed the estimate of $32.2M.
Browse earnings estimates, EPS, and revenue on all stocks.